期刊文献+

不同时相移植人骨髓间充质干细胞对人脐血CD34^+细胞植入NOD/SCID小鼠的影响 被引量:13

Hematopoietic Reconstitution by Co-transplantation of Human BM-MSCs and UCB CD34^+ Cells at Various Time in NOD/SCID Mice
下载PDF
导出
摘要 为了观察不同时相移植人骨髓间充质干细胞(MSC)对脐血(UCB)CD34+细胞移植的NOD/SCID小鼠造血重建的影响,明确最佳的移植时机,将体外培养扩增的人骨髓MSC分别于c细胞移植同时、移植前48小时及移植后48小时输入经60Coγ射线照射的NOD/SCID小鼠,观察共移植后42天内小鼠外周血白细胞和血小板变化,并于移植后42天处死小鼠,用FACS检测外周血、骨髓和脾脏人源细胞含量。结果表明:(1)MSC和UCB CD34+细胞同时输注可明显降低外周血白细胞和血小板下降幅度,缩短白细胞和血小板恢复时间;二者不同时输注均不降低白细胞和血小板下降幅度,且输注UCB CD34+细胞后48小时输注MSC时外周血血小板恢复时间明显晚于同时输注者。(2)与单纯UCB CD34+细胞移植相比较,不同时相输注MSC均可促进UCB CD34+细胞的植入,三个共输注组间促进骨髓各系造血植入效应无明显差异。结论:人骨髓MSC与UCB CD34+细胞共移植时,以同时移植效果最佳,此结果为MSC的临床应用提供了实验依据。 To investigate the effect of co-transplantation of bone marrow derived MSCs and UCB CD34^+ cells at different time points on hematopoietic reconstitution, all NOD/SCID mice were sublethally exposed to irradiation of ^60Co γ ray and transplanted with UCB CD34^+ with or without MSCs (3 mice per group). Animals were divided into HSC group and MSC + HSC group (M + H group). In HSC group, 1 × 10^6 UCB CD34^+ cells for each mouse were infused within 4 - 6 hours after irradiation; the M + H group again was divided into 3 subgroups according to infusion sequence of MSCs and HSCs. (A) M + H simultaneously infused group: MSCs and UCB CD34^+ cells were infused simultaneously; (B)M +48H group: MSCs were infused within 4 -6 hours after irradiation, while UCB CD34^+ cells were infused at 48 hours after irradiation; (C)H +48M group: UCB CD34^+ cells were infused within 4 -6 hours after irradiation, while MSCs were infused at 48 hours after irradiation. In 3 subgroups infused amounts of MSCs and UCB CD34 ^+ cells all were 1 × 10^6 cells. From the 3rd day after transplantation, 20 μl peripheral blood was collected from the retroorbital plexus of mice every week until 42th day after transplantation. 42 days after transplantation, mice were sacrificed, and the percentages of human CD45, CD34, CD19 and CD1 lb in bone marrow, peripheral blood and spleen were detected by FACS. The results showed that ( 1 ) Co-transplantation of MSCs and UCB CD34^+ cells simutaneously ( M + H group) can mitigate the decrease of WBC and platelet levels (p 〈0.01 ) in peripheral blood, and accelated the hemato- poietic recovery. While co-transplantating MSCs and UCB CD34^+ cells at different time points (M +48H or H +48M), the similar effect was not observed (p 〉0.05). As far as platelets was concerned, the recovery of platelets in M +48H group was lagged behind that in M + H group(p 〈0.01 ). (2) Co-transplantation of MSCs at different time points enhan
出处 《中国实验血液学杂志》 CAS CSCD 2008年第2期355-359,共5页 Journal of Experimental Hematology
基金 国家"863"高技术发展项目 编号2002AA205051 上海市科委重大基础研究基金 编号03DJ14020
关键词 间充质干细胞 脐血CD34^+细胞 共移植 NOD/SCID小鼠 mesenchymal stem cell umbilical cord blood CD34^+ cell co-transplantation NOD/SCID mouse
  • 相关文献

参考文献19

  • 1Galotto M, Berisso G, Delfino L, et al. Stromal damage as consequence of high-dose chemo/radiotherapy in bone marrow transplant recipients. Exp Hematol, 1999 ;27 : 1460 - 1466 被引量:1
  • 2Mahmud N, Pang W, Cobbs C,et al. Studies of the route of administration and role of conditioning with radiation on unrelated allogeneic mismatched mesenchymal stem cell engraftment in a nonhuman primates model. Exp Hematol, 2004;32:494 -501 被引量:1
  • 3Kassem M. Mesenchymal stem cells: biological characteristics and potential clinical applications. Cloning Stem Cells, 2004 ; 6 : 369 - 374 被引量:1
  • 4Le-Blanc K, Pittenger M, Mesenchymal stem cells: progress toward promise. Cytotherapy, 2005 ;7:36 -45 被引量:1
  • 5Kan I, Melamed E, Often D. Integral therapeutic potential of bone marrow mesenchymal stem cells, Curt Drug Targets, 2005 ;6:31 - 41 被引量:1
  • 6Muguruma Y, Yahata T, Miyatake H, et al, Reconstitution of the functional human hematopoietic microenvironment derived from human mesenchymal stem cells in the murine bone marrow compartment, Blood, 2006;107 : 1878 - 1887 被引量:1
  • 7Lazarus HM, Koc ON, Devine SM,et al. Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients. Biol Blood Marrow Transplant, 2005 ; 11:389 - 398 被引量:1
  • 8Ball LM, Bernardo ME, Roelofs H, et al. Cotransplantation of ex vivo expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem cell transplantation. Blood, 2007 ; 110:2764 - 2767 被引量:1
  • 9Le-Blanc K, Samuelsson H, Gustafsson B, et al, Transplantation of mesenchymal stem cells to enhance engraftment of hematopoietic stem cells, Leukemia, 2007 ;21:1733 - 1738 被引量:1
  • 10Willy A, Noort, Alwine B, et al. Cotransplantation of mesenchymal stem cells enhance engraftment by promoting the homing of cord blood-derived CD34^+ cells in NOD/SCID mice. Blood, 2002 ; 100 : 181b - 182b 被引量:1

同被引文献165

引证文献13

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部